NCT02145377View on ClinicalTrials.gov

PXVX0200 (CVD103-HgR) vs Shanchol in Mali

PHASE2CompletedINTERVENTIONAL

Enrollment

150

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions

Cholera

Interventions

BIOLOGICAL

PXVX0200 10E8

Oral dose of PXVX0200 10E8

BIOLOGICAL

PXVX0200 10E9

Oral dose of PXVX0200 10E9

BIOLOGICAL

Placebo

Oral dose of sodium bicarbonate buffer

BIOLOGICAL

Shanchol

Licensed comparator

Trial Locations (1)

Unknown

Centre pour le Développement des Vaccins, Mali (CVD-Mali), Bamako

Sponsors

Collaborators (1)

Emergent BioSolutions

All Listed Sponsors

collaborator

Emergent BioSolutions

INDUSTRY

collaborator

Shantha Biotechnics Limited

INDUSTRY

lead

University of Maryland, Baltimore

OTHER